| 二肽基肽酶4抑制剂对骨代谢影响的研究进展 |
| |
| 引用本文： | 王玉莹,刘蕴玲. 二肽基肽酶4抑制剂对骨代谢影响的研究进展[J]. 中国糖尿病杂志, 2022, 0(2) |
| |
| 作者姓名： | 王玉莹 刘蕴玲 |
| |
| 作者单位： | 山东第一医科大学第一附属医院（山东省千佛山医院）老年医学科 |
| |
| 摘 要： | DM患者患骨质疏松症的患病风险较高。二肽基肽酶4(DPP-4)广泛表达于全身组织器官。DPP-4抑制剂通过诱导间充质干细胞分化、减少AGEs聚集、增加IGF-1自分泌、抑制炎症因子表达、延长GLP-1及葡萄糖依赖性促胰岛素分泌多肽半衰期、促进APN分泌、改善维生素D水平、降低硬骨素水平等途径,对骨代谢产生一定影响。本文对DPP-4抑制剂对骨代谢的研究进展进行综述,旨在为临床治疗DM合并骨质疏松症提供依据。
|
| 关 键 词： | 二肽基肽酶4抑制剂 骨代谢 |
Research progress of dipeptidyl peptidase 4 inhibitors on bone metabolism |
| |
| WANG Yuying,LIU Yunling. Research progress of dipeptidyl peptidase 4 inhibitors on bone metabolism[J]. Chinese Journal of Diabetes, 2022, 0(2) |
| |
| Authors: | WANG Yuying LIU Yunling |
| |
| Affiliation: | (Department of Gerontology,The First Affiliated Hospital of Shandong First Medical University&Shandong Provincial Qianfoshan Hospital,Jinan 250014,China) |
| |
| Abstract: | Patients with diabetes mellitus(DM)have an increased risk of osteoporosis.Dipeptidyl peptidase 4(DPP-4)is widely expressed in various tissues and organs..DPP-4 inhibitor can induce the differentiation of mesenchymal stem cells,reduce the accumulation of advanced glycation end(AGE)products,increase the autocrine of IGF-1,inhibit the expression of inflammatory factors,prolong the half-life of glucagon like peptide 1 and glucose dependent insulin-stimulating peptide,promote the secretion of APN,improve the level of Vitamin D,and reduce the level of osteocalcin.This article reviews the research progress of DPP-4 inhibitors on bone metabolism in order to provide basis for clinical treatment of DM with osteoporosis. |
| |
| Keywords: | Dipeptidyl peptidase 4 inhibitors Bone metabolism |
| 本文献已被 维普 等数据库收录！ |
|
